Sogrya subcutaneous injection 15mg, manufactured by Novo Nordisk Pharma, contains Somatropin (genetically recombined) and is a once-weekly human growth hormone analog for treating growth hormone deficiency in pediatric patients and adults. It is supplied as 15 mg/1.5 mL/kit, with YJ code 2412403G3022.
Sogrya subcutaneous injection 15mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →